Gestonorone

This classification denotes a therapeutic progestin with the molecular formula C20H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H4G605B7VP, chemically known as 19-norpregn-4-ene-3,20-dione, 17-hydroxy- but generally known as gestonorone, which bears US NIH Compound Identifier 102210. European Medicines Agency schedules Gestonorone caproate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07902MIG. The term GESTONORONE CAPROATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules gestonorone in its Anatomical Therapeutic Chemical (ATC) Classification. GESTONORONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, GESTONORONE remains the US FDA Preferred Term for this commodity. SMILES: CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)O.